Bellevue Group AG 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 2:38 pm Purchase | 2026-03-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Bellevue Group AG | 6,726,144 6.600% | 6,726,144 (New Position) | Filing |